Liver resection (LR) for patients with hepatocellular carcinoma (HCC) and chronic liver
disease (CLD) poses a high risk of serious postoperative complications and multicentric …

Objective: This article reviews the basic principles, equipment, current therapeutic status and
future trends of microwave ablation (MWA) in the treatment of hepatocellular carcinoma …

Background & Aims No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …

Objective: To compare the results of percutaneous local ablative therapy (PLAT) with
surgical resection in the treatment of solitary and small hepatocellular carcinoma (HCC) …

Background & Aims The aim of this randomized comparative trial (RCT) is to compare partial
hepatectomy (PH) with transcatheter arterial chemoembolization (TACE) to treat patients …

Background Postsurgical recurrence of hepatocellular carcinoma (HCC) is frequent and
fatal. Adoptive immunotherapy is active against HCC. We assessed whether postoperative …

Background: Single-agent doxorubicin has been widely used to treat unresectable
hepatocellular carcinoma (HCC), but the response rate is low (< 20%) and there is no …

Objective Using a large single-institution experience at a Western referral center, the authors
examine partial hepatectomy as treatment of hepatocellular carcinoma and relate treatment …

Cancer care has been the subject of increased scrutiny, with the development of care
guidelines forming a major part of the strategy to reduce cancer related mortality in the UK …

Objective This study aimed to evaluate the long-term results of treatment and prognostic
factors in patients with intrahepatic recurrence after curative resection of hepatocellular …